Biogen Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and | Outperform |
16
|
$770.00 | $636.99 | 13.96% | 9 | $693.31B |
NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr903.30 | kr696.07 | 6.55% | 14 | kr4.01T |
JNJ | Johnson & Johnson | Outperform |
9
|
$154.64 | $174.55 | 9.93% | 3 | $372.17B |
MRK | Merck | Outperform |
2
|
$131.19 | $130.51 | 9.00% | 11 | $332.28B |
ABBV | AbbVie | Outperform |
9
|
$166.42 | $178.42 | 9.66% | 11 | $293.88B |
AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | £165.99 | 34.64% | 16 | £187.73B |
ROG | Roche Holding | Hold |
16
|
CHF237.10 | CHF307.83 | 14.93% | 9 | CHF191.28B |
NOVN | Novartis | Hold |
10
|
CHF93.37 | CHF105.00 | 15.26% | 9 | CHF190.51B |
DHR | Danaher | Outperform |
10
|
$265.80 | $260.33 | 2.49% | 4 | $196.87B |
AMGN | Amgen | Outperform |
4
|
$312.47 | $303.65 | 2.41% | 8 | $167.62B |
PFE | Pfizer | Outperform |
2
|
$28.64 | $32.87 | 6.49% | 6 | $162.29B |
SAN | Sanofi | Outperform |
16
|
89.17€ | 102.80€ | 22.80% | 9 | 111.47€B |
MDT | Medtronic | Outperform |
11
|
$85.92 | $92.47 | 11.73% | 9 | $114.09B |
VRTX | Vertex Pharmaceuticals Inc | Outperform |
12
|
$445.21 | $457.59 | 2.70% | 11 | $114.89B |
REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$982.29 | $961.26 | 6.89% | 8 | $105.97B |
CSL | CSL | Outperform |
12
|
$280.00 | $205.51 | -26.66% | 5 | $135.31B |
GSK | GSK | Outperform |
12
|
£17.75 | £17.30 | 12.39% | 12 | £72.39B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | $58.15 | 22.64% | 10 | $89.25B |
GILD | Gilead Sciences Inc | Outperform |
11
|
$67.72 | $87.82 | 18.13% | 14 | $84.36B |
MRK | Merck KGaA | Outperform |
18
|
167.20€ | 190.06€ | 6.46% | 4 | 72.69€B |
ZTS | Zoetis | Outperform |
18
|
$174.06 | $220.47 | 24.67% | 5 | $79.42B |
MRNA | Moderna | Outperform |
16
|
$132.90 | $135.42 | -5.19% | 1 | $50.93B |
4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 8.96% | 0 | ¥6.48T |
DSFIR | DSM-Firmenich | Outperform |
18
|
107.45€ | 114.60€ | 11.68% | 0 | 28.50€B |
BAYN | Bayer | Hold |
5
|
28.58€ | 45.15€ | 4.97% | 4 | 28.08€B |
DIM | Sartorius Stedim Biotech | Outperform |
18
|
196.80€ | 254.69€ | 21.95% | 3 | 19.15€B |
ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$149.40 | $245.24 | 45.58% | 7 | $18.90B |
GMAB | Genmab A/S | Outperform |
16
|
kr2.04k | kr2.71k | 29.35% | 14 | kr131.83B |
TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | $11.59 | 4.36% | 9 | $18.45B |
4503 | Astellas Pharma | Outperform |
18
|
¥1.49k | ¥2.64k | 34.50% | 0 | ¥2.67T |
CE | Celanese | Hold |
13
|
$157.34 | $148.23 | 6.14% | 18 | $17.18B |
SY1 | Symrise | Outperform |
18
|
102.40€ | 106.97€ | 7.42% | 5 | 14.31€B |
BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$77.56 | $111.56 | 42.47% | 5 | $14.62B |
4523 | Eisai | Outperform |
18
|
¥6.78k | ¥9.58k | 23.91% | 0 | ¥1.97T |
SRPT | Sarepta Therapeutics | Outperform |
6
|
$131.38 | $158.66 | 26.35% | 6 | $12.51B |
UTHR | United Therapeutics | Outperform |
12
|
$274.26 | $284.08 | 9.39% | 3 | $11.80B |
500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp5.80k | Rp5.67k | 4.32% | 25 | Rp977.65B |
SOBI | Swedish Orphan Biovitrum AB (p... | Outperform |
16
|
kr277.00 | kr293.00 | 17.33% | 6 | kr96.39B |
CRDA | Croda International Plc | Outperform |
18
|
£47.08 | £65.12 | 8.33% | 6 | £6.81B |
GRF | Grifols | Outperform |
18
|
9.89€ | 18.48€ | 80.99% | 3 | 5.85€B |
IONS | Ionis Pharmaceuticals | Outperform |
9
|
$37.31 | $55.60 | 60.81% | 3 | $5.76B |
WCH | Wacker Chemie | Outperform |
17
|
103.15€ | 145.36€ | 21.18% | 9 | 5.00€B |
CLN | Clariant | Outperform |
18
|
CHF14.42 | CHF16.11 | 10.96% | 6 | CHF4.67B |
BIOCON | Biocon | Hold |
14
|
Rp305.85 | Rp270.86 | -6.82% | 14 | Rp365.06B |
PRGO | Perrigo Co PLC | Outperform |
16
|
$29.83 | $44.75 | 34.09% | 0 | $4.19B |
ALKS | Alkermes | Outperform |
10
|
$24.15 | $33.27 | 32.51% | 3 | $4.11B |
4403 | NOF | Buy |
18
|
¥2.06k | ¥7.63k | 37.26% | 0 | ¥505.28B |
TGTX | TG Therapeutics | Outperform |
9
|
$16.48 | $29.44 | 109.34% | 6 | $2.38B |
DYN | Dyne Therapeutics | Buy |
5
|
$27.68 | $28.13 | 31.86% | 0 | $2.27B |
DCPH | Deciphera Pharmaceuticals | Hold |
6
|
$25.46 | $23.40 | 2.12% | 4 | $2.19B |
4516 | Nippon Shinyaku | Outperform |
18
|
¥3.70k | ¥8.34k | 75.77% | 0 | ¥261.33B |
WVE | Wave Life Sciences | Outperform |
6
|
$6.26 | $9.21 | 91.69% | 3 | $688.23M |
STOK | Stoke Therapeutics | Buy |
4
|
$13.90 | $19.33 | 43.88% | 3 | $604.59M |
ABUS | Arbutus Biopharma | Outperform |
9
|
$2.98 | $6.34 | 83.89% | 0 | $535.96M |
FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.55 | $10.21 | 92.05% | 7 | $456.83M |
AMRN | Amarin | Hold |
8
|
$0.87 | $2.05 | 14.94% | 1 | $378.19M |
NKTR | Nektar Therapeutics | Hold |
11
|
$1.76 | $2.75 | -9.09% | 2 | $301.14M |
CHRS | Coherus BioSciences | Outperform |
6
|
$2.12 | $10.86 | 277.36% | 3 | $255.37M |
PYC | PYC Therapeutics | Buy |
8
|
$0.10 | $0.30 | 260.00% | 1 | $294.90M |
MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.17 | $0.65 | 488.24% | 0 | $44.04M |
ACST | Acasti Pharma | Buy |
0
|
$2.69 | $16.34 | 199.63% | 0 | $26.98M |
542934 | Chandra Bhagat Pharma | - |
0
|
Rp114.60 | Rp0.00 | -100.00% | 0 | Rp866.55M |
ENZN | Enzon Pharmaceuticals | - |
0
|
$0.09 | $16.00 | -100.00% | 0 | $8.48M |
ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $0.53M |
NPHC | Nutra Pharma | - |
0
|
$0.00 | $0.53 | 0.00% | 0 | $0.01M |
CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |